![Charbel Helaihel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Charbel Helaihel worked as the VP-Marketing & Commercial Planning at Inhibrx, Inc. from 2023 to 2024.
He completed his undergraduate degree at Beirut Arab University.
Antiguos cargos conocidos de Charbel Helaihel.
Empresas | Cargo | Fin |
---|---|---|
INHIBRX, INC. | Ventas & Marketing | 30/05/2024 |
Formación de Charbel Helaihel.
Beirut Arab University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Inhibrx, Inc.
![]() Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Charbel Helaihel